A Kinetoplastid-specific protein. Unlikely to be a membrane protein.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A4H944
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 17 | 21 | PF00656 | 0.473 |
CLV_C14_Caspase3-7 | 188 | 192 | PF00656 | 0.426 |
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.486 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 276 | 278 | PF00675 | 0.558 |
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.589 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.440 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.569 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.589 |
CLV_PCSK_SKI1_1 | 183 | 187 | PF00082 | 0.487 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.502 |
DOC_CKS1_1 | 110 | 115 | PF01111 | 0.476 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 171 | 180 | PF00134 | 0.336 |
DOC_MAPK_MEF2A_6 | 204 | 212 | PF00069 | 0.481 |
DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.512 |
DOC_USP7_MATH_1 | 268 | 272 | PF00917 | 0.549 |
DOC_USP7_MATH_1 | 352 | 356 | PF00917 | 0.401 |
DOC_USP7_MATH_1 | 64 | 68 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 73 | 77 | PF00917 | 0.551 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.644 |
DOC_USP7_UBL2_3 | 278 | 282 | PF12436 | 0.591 |
DOC_WW_Pin1_4 | 106 | 111 | PF00397 | 0.649 |
DOC_WW_Pin1_4 | 262 | 267 | PF00397 | 0.698 |
DOC_WW_Pin1_4 | 341 | 346 | PF00397 | 0.489 |
DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.606 |
LIG_14-3-3_CanoR_1 | 197 | 205 | PF00244 | 0.361 |
LIG_14-3-3_CanoR_1 | 241 | 247 | PF00244 | 0.511 |
LIG_14-3-3_CanoR_1 | 41 | 47 | PF00244 | 0.440 |
LIG_Actin_WH2_2 | 322 | 340 | PF00022 | 0.489 |
LIG_BIR_III_4 | 191 | 195 | PF00653 | 0.471 |
LIG_CaM_IQ_9 | 269 | 284 | PF13499 | 0.492 |
LIG_CtBP_PxDLS_1 | 209 | 213 | PF00389 | 0.497 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.653 |
LIG_FHA_1 | 159 | 165 | PF00498 | 0.479 |
LIG_FHA_1 | 267 | 273 | PF00498 | 0.736 |
LIG_FHA_1 | 310 | 316 | PF00498 | 0.466 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.480 |
LIG_FHA_1 | 7 | 13 | PF00498 | 0.463 |
LIG_FHA_2 | 186 | 192 | PF00498 | 0.415 |
LIG_FHA_2 | 256 | 262 | PF00498 | 0.525 |
LIG_FHA_2 | 338 | 344 | PF00498 | 0.540 |
LIG_Integrin_RGD_1 | 301 | 303 | PF01839 | 0.649 |
LIG_PCNA_yPIPBox_3 | 227 | 239 | PF02747 | 0.351 |
LIG_SH2_SRC | 92 | 95 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.598 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.602 |
LIG_SH3_3 | 346 | 352 | PF00018 | 0.399 |
LIG_SUMO_SIM_anti_2 | 314 | 321 | PF11976 | 0.362 |
LIG_SUMO_SIM_anti_2 | 357 | 363 | PF11976 | 0.427 |
LIG_SUMO_SIM_anti_2 | 4 | 9 | PF11976 | 0.462 |
LIG_SUMO_SIM_par_1 | 346 | 351 | PF11976 | 0.383 |
LIG_SUMO_SIM_par_1 | 4 | 9 | PF11976 | 0.488 |
LIG_TRAF2_1 | 258 | 261 | PF00917 | 0.601 |
LIG_WRC_WIRS_1 | 186 | 191 | PF05994 | 0.408 |
MOD_CK1_1 | 102 | 108 | PF00069 | 0.609 |
MOD_CK1_1 | 281 | 287 | PF00069 | 0.574 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.517 |
MOD_CK2_1 | 255 | 261 | PF00069 | 0.523 |
MOD_CK2_1 | 337 | 343 | PF00069 | 0.451 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.595 |
MOD_GlcNHglycan | 284 | 287 | PF01048 | 0.575 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.612 |
MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.474 |
MOD_GlcNHglycan | 354 | 357 | PF01048 | 0.452 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.563 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.594 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.555 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.599 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.569 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.376 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.658 |
MOD_GSK3_1 | 278 | 285 | PF00069 | 0.609 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.609 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.563 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.578 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.584 |
MOD_LATS_1 | 280 | 286 | PF00433 | 0.489 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.637 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.475 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.597 |
MOD_NEK2_2 | 160 | 165 | PF00069 | 0.439 |
MOD_PIKK_1 | 197 | 203 | PF00454 | 0.344 |
MOD_PIKK_1 | 58 | 64 | PF00454 | 0.562 |
MOD_PKA_2 | 196 | 202 | PF00069 | 0.403 |
MOD_PKA_2 | 240 | 246 | PF00069 | 0.585 |
MOD_PKA_2 | 337 | 343 | PF00069 | 0.561 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.532 |
MOD_PKA_2 | 68 | 74 | PF00069 | 0.689 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.620 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.440 |
MOD_ProDKin_1 | 106 | 112 | PF00069 | 0.645 |
MOD_ProDKin_1 | 262 | 268 | PF00069 | 0.696 |
MOD_ProDKin_1 | 341 | 347 | PF00069 | 0.479 |
MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.606 |
TRG_ER_diArg_1 | 10 | 12 | PF00400 | 0.441 |
TRG_ER_diArg_1 | 182 | 184 | PF00400 | 0.447 |
TRG_Pf-PMV_PEXEL_1 | 218 | 223 | PF00026 | 0.411 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKU0 | Leptomonas seymouri | 43% | 74% |
A0A1X0NT51 | Trypanosomatidae | 27% | 76% |
A0A3Q8ICU3 | Leishmania donovani | 79% | 100% |
A0A3R7JY32 | Trypanosoma rangeli | 26% | 83% |
C9ZP32 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 82% |
E9AR53 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q4QEB0 | Leishmania major | 76% | 100% |
V5B6D3 | Trypanosoma cruzi | 25% | 80% |